Mindbeacon Therapist Assisted Internet Delivered CBT for Depression

Last updated: April 14, 2023
Sponsor: Ontario Shores Centre for Mental Health Sciences
Overall Status: Trial Not Available

Phase

N/A

Condition

Depression

Affective Disorders

Depression (Major/severe)

Treatment

N/A

Clinical Study ID

NCT05134103
21-004-B
  • Ages > 18
  • All Genders

Study Summary

Utilization of therapist Assisted internet-delivered cognitive behavioural therapy (TAiCBT) for treating depression and anxiety disorders in stepped-care models, such as the UK's Improving Access to Psychological Therapies (IAPT) and the Ontario Structured Psychotherapy Program (SPP), is a potential solution for addressing the treatment gap in mental health. Investigators propose to investigate the effectiveness of Beacon TAiCBT for Depression to demonstrate the potential value of TAiCBT in a stepped care model. Investigators propose to conduct a 12-week pragmatic randomized controlled trial with a 1:1 (iCBT intervention: waiting-list) allocation, for participants referred to the Anxiety and Mood, Prompt Anxiety and Mood, and Trauma Programs at Ontario Shores Centre for Mental Health Sciences and on a waiting-list to receive clinical service.

The primary outcome measures will be the Improving Access to Psychological Therapies (IAPT) definitions of Recovery, Reliable Improvement, and Reliable Recovery which are derived using the PHQ-9 and GAD-7 . The PHQ-9 (Depression), GAD-7 (anxiety) and WSAS (functional impairment) will be used as secondary outcome measures for all participants.

Over the course of the study, 200 participants will be randomized (iCBT, 100; waiting-list, 100). Statistical analyses will include intention-to-treat analyses to test the interaction effects for the primary outcome measures at discharge/12-weeks and 3, and 12 months post-treatment.

It is predicted that participants in the treatment condition will show significantly reduced symptoms of depression related to the waitlist control. It is predicted that this will be maintained through follow up.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Minimum age of 18 years
  • Meets Diagnostic Assessment Research Tool (DART) screening criteria for a primarydiagnosis of depression and reports being at least moderately depressed according tothe PHQ-9
  • Sufficient language proficiency to understand the treatment materials written at grade 10 reading level
  • Understands what TAiCBT and is open and interested to participating in a study usingthis treatment modality
  • Is able to reliably access the internet, and has basic computer skills to navigate theinternet using a web browser
  • Willing to participate in a waitlist-control study and be followed for 12 months

Exclusion

Exclusion Criteria:

  • Suicidal intent or clinically significant suicidal ideation
  • Clinically significant self-harm
  • Active psychotic illness
  • Currently participating in psychological treatment for depression and/or receivingevidence-based treatment (other than medication) for depression
  • Clinically significant alcohol and/or other substance use including prescription andover the counter medication that would likely interfere with treatment
  • Current or previous diagnosis of Borderline Personality Disorder
  • Does not meet DART criteria for a primary diagnosis of depression
  • Change in psychotropic medication within 3 weeks of treatment baseline

Study Design

Study Start date:
November 01, 2021
Estimated Completion Date:
November 18, 2021